Randomised, placebo-controlled multicentre trial of clodronate in multiple myeloma

The Lancet

Volumn 340, Issue 8827, 1992, Pages 1049-1052

  Lahtinen, Reino ^a   Laakso, Markku ^a   Palva, Ilmari ^b   Elomaa, Inkeri ^c   Virkkunen, Pekka ^c  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Hatanpää Hospital   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; CLODRONIC ACID; CYCLOPHOSPHAMIDE; LOMUSTINE; MELPHALAN; METHYLPREDNISOLONE; PLACEBO; PREDNISOLONE; VINCRISTINE;

ADULT; AGED; ANALGESIA; ARTICLE; CLINICAL TRIAL; COMPLICATION; CONTROLLED STUDY; DRUG THERAPY; FEMALE; FINLAND; FRACTURE; HUMAN; HYPERCALCEMIA; HYPERCALCIURIA; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MULTIPLE MYELOMA; ORAL DRUG ADMINISTRATION; OSTEOLYSIS; PREVENTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BONE DISEASES; CALCIUM; CLODRONIC ACID; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; FRACTURES, SPONTANEOUS; HUMAN; HYPERCALCEMIA; MALE; MIDDLE AGE; MULTIPLE MYELOMA; PAIN; PLACEBOS;

EID: 0026646339     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/0140-6736(92)93075-X     Document Type: Article

References (28)

1. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lyric bone disease
2. Bone resorption and turnover in health and disease
3. 2MDP (diclormethylene diphosphonate) on bone resorption
4. Multiple myeloma, macroglobulinaemia and monoclonal gammopathies
5. The pathophysiology of hypercalcaemia
6. Effects of amino-butylidene diphosphonate in hypercalcaemia due to malignancy
7. A computer program for comparing k samples with right-censored data
8. Bone histomorphometry in Paget's disease
9. 2MDP) in Paget's disease of bone
10. Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases
11. Effect of dichloromethylene diphosphonate in Paget's disease of bone and hypercalcaemia due to primary hyperparathyroidism or malignant disease
12. Long-term controlled trial with diphosphonate in patients with bone metastases
13. Disodium clodronate in the treatment of pain due to bone metastases
14. Bisphosphonates and bone metastases
15. Rationale for the use of bisphosphonates in bone metastases
16. Effect of daily etidronate on the osteolysis of multiple myeloma
17. 2MDP) on skeletal lesions in multiple myeloma
18. Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma
19. 2MBP) on bone disease of myeloma patients treated with chemotherapy
20. Clodronate: a randomized study in the treatment of cancer-related hypercalcemia
21. Hypercalcemia of malignancy: treatment with intravenous dichloromethylene diphosphonate
22. Treatment of hypercalcaemia of malignancy with intravenous clodronate
23. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate
24. Treatment of malignant hypercalcaemia with clodronate
25. The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma
26. Multiple myeloma: review of 869 cases
27. The use of clodronate in disorders of calcium and skeletal metabolism